United Asset Strategies Inc. Cuts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

United Asset Strategies Inc. reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.0% in the third quarter, according to its most recent filing with the SEC. The fund owned 2,381 shares of the medical equipment provider’s stock after selling 24 shares during the quarter. United Asset Strategies Inc.’s holdings in Intuitive Surgical were worth $1,170,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Mirador Capital Partners LP boosted its position in shares of Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after acquiring an additional 50 shares during the last quarter. Advisors Asset Management Inc. lifted its position in Intuitive Surgical by 18.1% in the first quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock worth $2,945,000 after buying an additional 1,129 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its position in Intuitive Surgical by 617.1% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock worth $39,622,000 after buying an additional 76,649 shares during the last quarter. Brookstone Capital Management lifted its position in Intuitive Surgical by 22.4% in the second quarter. Brookstone Capital Management now owns 12,530 shares of the medical equipment provider’s stock worth $5,340,000 after buying an additional 2,289 shares during the last quarter. Finally, M&G Plc lifted its position in Intuitive Surgical by 53.5% in the second quarter. M&G Plc now owns 5,069 shares of the medical equipment provider’s stock worth $2,256,000 after buying an additional 1,766 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Down 1.9 %

Intuitive Surgical stock opened at $503.84 on Friday. Intuitive Surgical, Inc. has a 52 week low of $260.17 and a 52 week high of $523.34. The company has a market capitalization of $179.46 billion, a price-to-earnings ratio of 81.00, a price-to-earnings-growth ratio of 5.05 and a beta of 1.39. The stock has a 50-day moving average price of $490.01 and a 200 day moving average price of $445.70.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 240 shares of the business’s stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $464.76, for a total value of $111,542.40. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,558,968.56. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, EVP Robert Desantis sold 240 shares of the business’s stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $464.76, for a total value of $111,542.40. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,558,968.56. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 68,246 shares of company stock valued at $33,839,308. 0.90% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their price target for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Piper Sandler reiterated an “overweight” rating and issued a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Citigroup increased their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Finally, The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.